Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central nervous system lymphoma.

Andrew Lister1, Lauren E Abrey, John T Sandlund

  • 1St. Bartholomew's Hospital, West Smithfield, London, United Kingdom.

Hematology. American Society of Hematology. Education Program
|November 26, 2002
PubMed
Summary

Central nervous system lymphoma, though uncommon, significantly impacts patients with blood cancers. This review highlights strategies for primary CNS lymphoma and preventing CNS leukemia in childhood acute lymphoblastic leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to "Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues".

ACS chemical biology·2026
Same author

Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues.

ACS chemical biology·2026
Same author

Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Author Correction: Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding.

Communications chemistry·2025
Same author

Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding.

Communications chemistry·2025
Same author

Enantioconvergent nucleophilic substitution via synergistic phase-transfer catalysis.

Nature catalysis·2025

Area of Science:

  • Oncology
  • Neurology
  • Hematology

Background:

  • Central nervous system (CNS) involvement in malignant lymphoma, primary or secondary, is an infrequent yet significant complication in patients with hematological malignancies.
  • This complication is associated with substantial morbidity and mortality, often due to therapeutic limitations.

Purpose of the Study:

  • To provide a comprehensive overview of primary CNS lymphoma, focusing on systemic chemotherapy approaches.
  • To review therapeutic strategies for acute lymphoblastic leukemia in childhood, identifying high-risk patients for CNS leukemia and outlining preventive measures.
  • To discuss secondary CNS lymphoma involvement and prophylaxis indications.

Main Methods:

  • Review of primary CNS lymphoma management strategies, emphasizing systemic chemotherapy.

Related Experiment Videos

  • Analysis of sequential clinical trials for childhood acute lymphoblastic leukemia to identify CNS leukemia risk factors and prevention strategies.
  • Discussion of secondary CNS lymphoma and prophylaxis guidelines.

    • Main Results:

    • Systemic chemotherapy is increasingly central to managing primary CNS lymphoma.
    • Risk stratification and targeted prevention strategies have improved outcomes for childhood acute lymphoblastic leukemia, reducing CNS involvement.
    • Prophylaxis for secondary CNS lymphoma is crucial for specific patient groups.

    Conclusions:

    • Effective management of CNS lymphoma requires tailored approaches for both primary and secondary disease.
    • Early identification and prevention strategies are vital for minimizing CNS complications in hematological malignancies, particularly in pediatric leukemia.
    • Further research into optimal therapeutic strategies for CNS lymphoma is warranted to improve patient outcomes.